Managing BRCA Mutation Carriers10.1007/978-3-319-59198-8_82017135-150Medical Management of Breast Cancer in BRCA Mutation CarriersSoley Bayraktar, Banu K. Arun
Managing BRCA Mutation Carriers10.1007/978-3-319-59198-8_72017119-134Surgical Management of Breast Cancer in BRCA Mutation CarriersPatricia A. Cronin, Hiram S. Cody
The Breast10.1016/s0960-9776(19)30087-6201944S9Is prophylactic mastectomy justified in women without BRCA mutation?E. Rutgers,
The Breast10.1016/s0960-9776(19)31126-9201948S62-S64Is prophylactic mastectomy justified in women without BRCA mutation?Emiel J.T. Rutgers,
Managing BRCA Mutation Carriers10.1007/978-3-319-59198-8_92017151-170Radiation Oncology Considerations in the Management of Mutation Carriers with Breast CancerMeena S. Moran
The Breast10.1016/s0960-9776(17)30164-9201732S44-S45Whole exome sequencing revealed a novel 1-bp PALB2 deletion mutation (D434fs) in a breast cancer patient with a BRCA1 variant of uncertain clinical significance.A. Peeters, C. Van Heerden, M. Kotze,
Human Mutation10.1002/humu.221942013349iv-ivWhole Exome Sequencing to Map the Genomic Evolution of Metastatic Prostate CancerTerence Friedlander,
Breast Cancer Research and Treatment10.1007/s10549-012-2158-620121352355-366Systemic therapy options in BRCA mutation-associated breast cancerSoley Bayraktar, Stefan Glück,,
Breast Cancer Research and Treatment10.1007/s10549-014-2902-120141443607-614The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutationPål Møller, Astrid Stormorken, Marit Muri Holmen, Anne Irene Hagen, Anita Vabø, Lovise Mæhle,,
The Lancet Oncology10.1016/s1470-2045(07)70348-020078121042-1043Breast-cancer risk in BRCA -mutation-negative women from BRCA -mutation-positive familiesHormuzd A Katki, Mitchell H Gail, Mark H Greene,